क्यूआर कोड

EGFR-D770>GY and Other Rare EGFR Exon 20 Insertion Mutations with a G770 Equivalence Are Sensitive to Dacomitinib or Afatinib and Responsive to EGFR Exon 20 Insertion Mutant-Active Inhibitors in Preclinical Models and Clinical Scenarios

<i>Epidermal growth factor receptor</i> (<i>EGFR</i>) exon 20 insertion mutations account for a tenth of all <i>EGFR</i> mutations in lung cancers. An important unmet clinical need is the identification of EGFR exon 20 insertion mutants that can respond to multiple classes of approved EGFR-TKIs. We...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Ikei S. Kobayashi, Hollis Viray, Deepa Rangachari, Susumu S. Kobayashi, Daniel B. Costa
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2021-12-01
श्रृंखला:Cells
विषय:
lung cancer
EGFR exon 20 insertion
D770&gt;GY
afatinib
dacomitinib
poziotinib
ऑनलाइन पहुंच:https://www.mdpi.com/2073-4409/10/12/3561
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन